SEC Comment Letter 0000000000-26-000658 to Shattuck Labs, Inc. (STTK)
Shattuck Labs, Inc.
Date: Jan. 16, 2026 · CIK: 0001680367 · Accession: 0000000000-26-000658
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292697
Letter
January 16, 2026 Taylor Schreiber, M.D., Ph.D. Chief Executive Officer Shattuck Labs, Inc. 500 W. 5th Street, Suite 1200 Austin, TX 78701 Re:Shattuck Labs, Inc. Registration Statement on Form S-3 Filed January 13, 2026 File No. 333-292697 Dear Taylor Schreiber M.D., Ph.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Melanie E. Neary, Esq.
Show Raw Text
January 16, 2026
Taylor Schreiber, M.D., Ph.D.
Chief Executive Officer
Shattuck Labs, Inc.
500 W. 5th Street, Suite 1200
Austin, TX 78701
Re:Shattuck Labs, Inc.
Registration Statement on Form S-3
Filed January 13, 2026
File No. 333-292697
Dear Taylor Schreiber M.D., Ph.D.:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Melanie E. Neary, Esq.